MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIES
Patrick G. Beatty(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Robert P. Witherspoon(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), F B Petersen(University of Washington), Paul J. Martin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Effie W. Petersdorf(University of Washington), Claudio Anasetti(Moffitt Cancer Center), Rainer Storb(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jean E. Sanders(Carolinas Medical Center), Margaret S. Pepe, MICHELE C. TESLER(University of Washington), Patricia Stewart(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Eric Mickelson(University of Washington), Reginald A. Clift(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), CD Buckner(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Scott I. Bearman(University of Washington), Fredrick R. Appelbaum(University of Washington), JOHN A. HANSEN(University of Washington), E. Donnall Thomas(AbbVie (United States)), Gary Longton(University of Washington), Keith M. Sullivan(Duke Medical Center)
Cited by 264
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Chronic graft-versus-host syndrome in man
|The American Journal of Medicine|1980|2.4k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide
|Biology of Blood and Marrow Transplantation|2008|1.9k
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
|New England Journal of Medicine|1995|1.8k
Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for Leukemia
|New England Journal of Medicine|1986|1.5k